Its Riley McCormack - 16 Jun 2026 Form 4 Insider Report for Digimarc Corp (DMRC)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: DMRC
Reported as of: 16 Jun 2026
Net transaction value: -$1,196,828
SEC form: 4
Accepted by SEC: 18 Jun 2026, 18:03:02 UTC
Prior SEC filing: 21 May 2026
Source filing: View source filing
Reporting owner signature: TCM Strategic Partners L.P., By: TCM Strategic GP LLC, its general partner, By: /s/ Riley McCormack, its manager

Key filing fact

Its Riley McCormack filed Form 4 for Digimarc Corp (DMRC) on 18 Jun 2026.

Key facts

This page summarizes Its Riley McCormack's Form 4 filing for Digimarc Corp (DMRC).
5 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Jun 2026, 18:03.

Change

Previous filing in this sequence was filed on 21 May 2026.
Current net transaction value: -$1,196,828.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (3)

CIK 0001536534 Primary reporting owner

mccormack riley

Relationship: Chief Executive Officer, Director
Address: 8500 SW CREEKSIDE PLACE, BEAVERTON
Signature: TCM Strategic Partners L.P., By: TCM Strategic GP LLC, its general partner, By: /s/ Riley McCormack, its manager
Signature date: 18 Jun 2026

CIK 0001827235

TCM Strategic Partners L.P.

Relationship: Former 10% Owner
Address: 8500 SW CREEKSIDE PLACE, BEAVERTON
Signature: TCM Strategic GP LLC, By: /s/ Riley McCormack, its manager
Signature date: 18 Jun 2026

CIK 0001827269

TCM Strategic GP LLC

Relationship: Former 10% Owner
Address: 8500 SW CREEKSIDE PLACE, BEAVERTON
Signature: /s/ Riley McCormack
Signature date: 18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DMRC transaction

Common Stock

Other

Transaction value
Shares: -2,275,737
Change %: -100%
Price
Shares after: 0
Date: 16 Jun 2026
Ownership: See Footnote
Footnotes: F1, F2

DMRC transaction

Common Stock

Other

Transaction value
Shares: -2,275,737
Change %: -100%
Price
Shares after: 0
Date: 16 Jun 2026
Ownership: See Footnote
Footnotes: F1, F2

DMRC transaction

Common Stock

Other

Transaction value
Shares: -2,275,737
Change %: -100%
Price
Shares after: 0
Date: 16 Jun 2026
Ownership: See Footnote
Footnotes: F1, F2

DMRC transaction

Common Stock

Sale

Transaction value: $751,458
Shares: -69,363
Change %: -62%
Price: $10.83
Shares after: 42,074
Date: 16 Jun 2026
Ownership: See Footnote
Footnotes: F1, F3, F4

DMRC transaction

Common Stock

Sale

Transaction value: $751,458
Shares: -69,363
Change %: -62%
Price: $10.83
Shares after: 42,074
Date: 16 Jun 2026
Ownership: See Footnote
Footnotes: F1, F3, F4

DMRC transaction

Common Stock

Sale

Transaction value: $751,458
Shares: -69,363
Change %: -62%
Price: $10.83
Shares after: 42,074
Date: 16 Jun 2026
Ownership: See Footnote
Footnotes: F1, F3, F4

DMRC transaction

Common Stock

Sale

Transaction value: $38,492
Shares: -3,512
Change %: -100%
Price: $10.96
Shares after: 0
Date: 16 Jun 2026
Ownership: See Footnote
Footnotes: F1, F5, F6, F7

DMRC transaction

Common Stock

Sale

Transaction value: $38,492
Shares: -3,512
Change %: -100%
Price: $10.96
Shares after: 0
Date: 16 Jun 2026
Ownership: See Footnote
Footnotes: F1, F5, F6, F7

DMRC transaction

Common Stock

Sale

Transaction value: $38,492
Shares: -3,512
Change %: -100%
Price: $10.96
Shares after: 0
Date: 16 Jun 2026
Ownership: See Footnote
Footnotes: F1, F5, F6, F7

DMRC transaction

Common Stock

Sale

Transaction value: $150,726
Shares: -15,003
Change %: -36%
Price: $10.05
Shares after: 27,071
Date: 17 Jun 2026
Ownership: See Footnote
Footnotes: F4, F8

DMRC transaction

Common Stock

Sale

Transaction value: $150,726
Shares: -15,003
Change %: -36%
Price: $10.05
Shares after: 27,071
Date: 17 Jun 2026
Ownership: See Footnote
Footnotes: F4, F8

DMRC transaction

Common Stock

Sale

Transaction value: $150,726
Shares: -15,003
Change %: -36%
Price: $10.05
Shares after: 27,071
Date: 17 Jun 2026
Ownership: See Footnote
Footnotes: F4, F8

DMRC transaction

Common Stock

Sale

Transaction value: $256,151
Shares: -27,071
Change %: -100%
Price: $9.46
Shares after: 0
Date: 18 Jun 2026
Ownership: See Footnote
Footnotes: F4, F9

DMRC transaction

Common Stock

Sale

Transaction value: $256,151
Shares: -27,071
Change %: -100%
Price: $9.46
Shares after: 0
Date: 18 Jun 2026
Ownership: See Footnote
Footnotes: F4, F9

DMRC transaction

Common Stock

Sale

Transaction value: $256,151
Shares: -27,071
Change %: -100%
Price: $9.46
Shares after: 0
Date: 18 Jun 2026
Ownership: See Footnote
Footnotes: F4, F9

DMRC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 64,659
Date: 16 Jun 2026
Ownership: Direct

DMRC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 64,659
Date: 16 Jun 2026
Ownership: Direct

DMRC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 64,659
Date: 16 Jun 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

On June 16, 2026, TCM Strategic Partners L.P. (the "TCM Fund") made an in-kind distribution of an aggregate 2,275,737 shares to its limited partners and its general partner, proportionately based on their respective limited partnership interests, for no consideration. Also on June 16, 2026, the TCM Fund transferred an additional 79,356 shares to TCM Strategic L.P. (the "TCM IM"), the investment manager of the TCM Fund, in a transaction exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-13 thereunder.

Footnote F2

The securities are directly owned by the TCM Fund. TCM Strategic GP LLC (the "TCM GP") is the general partner of the TCM Fund. Riley McCormack is the sole manager of the TCM GP. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of its or his indirect pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act or for any other purpose.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $10.50 to $11.355, inclusive. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The securities are directly owned by the TCM IM. Riley McCormack is the founder and sole owner of the TCM IM. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of its or his indirect pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act or for any other purpose.

Footnote F5

Includes 3,512 shares that were acquired by TCM GP pursuant to the pro-rata in-kind distribution by the TCM Fund on June 16, 2026, described in footnote 1 herein, which transaction was exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9 thereunder.

Footnote F6

This transaction was executed in multiple trades at prices ranging from $10.72 to $11.345, inclusive. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F7

The securities are directly owned by the TCM GP. Riley McCormack is the sole manager of the TCM GP. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of its or his indirect pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act or for any other purpose.

Footnote F8

This transaction was executed in multiple trades at prices ranging from $9.85 to $10.79, inclusive. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F9

This transaction was executed in multiple trades at prices ranging from $9.30 to $9.755, inclusive. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.